MetaCap

Who Owns Curanex Pharmaceuticals Stock?

NASDAQ: CURXHealthcareBiotechnologyUSD

4.76-0.045 (-0.94%)

At close: Oct 8, 4:00 PM ET · Delayed 15 min

Ownership breakdown

Held by institutions
1.06%
Institutional holders
11
  • Institutions 1.1%
  • Insiders 61.4%
  • Public and other 37.6%

Who owns Curanex Pharmaceuticals stock?

Institutional investors own about 1.1% of Curanex Pharmaceuticals's shares, spread across 11 institutions that file 13F reports. That level of institutional ownership is relatively low, leaving more of the stock with retail investors and insiders. Insiders, including executives, directors and large founding shareholders, hold 61.35% of CURX.

The largest institutional holders are Citadel Advisors Llc (0.30%), Renaissance Technologies, LLC (0.17%) and Virtu Financial LLC (0.16%). Together, the top 10 institutions control 1.1% of shares outstanding. In their latest filings, 7 of the top 10 institutions increased their CURX positions and 3 reduced them.

Summary generated from market data by MetaCap's automated system. Methodology

Top institutional holders of CURX

Curanex Pharmaceuticals top institutional holders
InstitutionShares% HeldChange
Citadel Advisors Llc4.76K0.30%+88.4%
Renaissance Technologies, LLC2.60K0.17%+100.0%
Virtu Financial LLC2.56K0.16%+100.0%
Geode Capital Management, LLC1.91K0.12%-65.6%
Jane Street Group, LLC1.56K0.10%+100.0%
Two Sigma Investments, LP1.37K0.09%+35.0%
Susquehanna International Group, LLP7330.05%+100.0%
Ground Swell Capital, LLC6320.04%+100.0%
Citigroup Inc.4480.03%-53.7%
UBS Group AG760.00%-81.0%

% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.

Top mutual fund and ETF holders of CURX

Curanex Pharmaceuticals top fund holders
FundShares% Held
Fidelity Concord Street Trust-Fidelity Extended Market Index Fund1.17K0.07%
Fidelity Concord Street Trust-Fidelity Nasdaq Composite Index Fund7480.05%

Frequently asked questions

Who is the largest shareholder of Curanex Pharmaceuticals?

Citadel Advisors Llc is the largest institutional shareholder of CURX, owning 0.30% of shares outstanding (4.76K shares) as of its latest 13F filing.

What percentage of Curanex Pharmaceuticals is owned by institutions?

Institutions own about 1.1% of CURX shares and 2.8% of the public float.

How much of Curanex Pharmaceuticals do insiders own?

Insiders, such as officers and directors, own about 61.35% of CURX shares outstanding.

Where does institutional ownership data come from?

Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.

Related